NO983984L - Disintegrin-metalloprotease samt anvendelse derav - Google Patents
Disintegrin-metalloprotease samt anvendelse deravInfo
- Publication number
- NO983984L NO983984L NO983984A NO983984A NO983984L NO 983984 L NO983984 L NO 983984L NO 983984 A NO983984 A NO 983984A NO 983984 A NO983984 A NO 983984A NO 983984 L NO983984 L NO 983984L
- Authority
- NO
- Norway
- Prior art keywords
- disintegrin
- protein
- binding
- expression vector
- recombinant expression
- Prior art date
Links
- 101800001224 Disintegrin Proteins 0.000 title abstract 6
- 102000005741 Metalloproteases Human genes 0.000 title abstract 3
- 108010006035 Metalloproteases Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000003259 recombinant expression Methods 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- General Physics & Mathematics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
Abstract
Det er beskrevet en fremgangsmåte for å identifisere forbindelser som er i stand til å binde til et disinte- grinprotein og bestemme mengden og affinitet av en for- bindelse som er i stand til å binde til disintegrinpro- teinet i en prøve. Det er også beskrevet en vertscelle omfattende en rekombinant ekspresjonsvektor for disintegrinproteinet og en rekombinant ekspresjons- vektor som koder for disintegrinproteinet og det humane disintegrinmetalloproteaseprotein, fragment eller mutant derav, som er anvendelig for disse formål. Det er også beskrevet en in vivo eller in vi tro metode for bestemmelse av osteoartritt og andre metalloprote- asebaserte sykdommer, og som er i stand til å bli frem- stilt og brukt i form av et sett.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1267996P | 1996-03-01 | 1996-03-01 | |
| PCT/US1997/003217 WO1997031931A1 (en) | 1996-03-01 | 1997-02-28 | A novel disintegrin metalloprotease and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983984D0 NO983984D0 (no) | 1998-08-28 |
| NO983984L true NO983984L (no) | 1998-11-02 |
Family
ID=21756171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983984A NO983984L (no) | 1996-03-01 | 1998-08-28 | Disintegrin-metalloprotease samt anvendelse derav |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0888375A4 (no) |
| JP (1) | JPH11506023A (no) |
| KR (1) | KR19990087444A (no) |
| AU (1) | AU2061797A (no) |
| CA (1) | CA2247827A1 (no) |
| NO (1) | NO983984L (no) |
| NZ (1) | NZ331844A (no) |
| WO (1) | WO1997031931A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6255064B1 (en) | 1996-03-01 | 2001-07-03 | The Procter & Gamble Company | Disintegrin metalloprotease and its use |
| EP0963432A4 (en) * | 1996-08-29 | 2002-11-20 | Univ California | KUZ, NEW FAMILY OF METALLOPROTEASES |
| HUP0100780A2 (hu) * | 1997-02-25 | 2001-06-28 | Case Western Reserve University | Új dezintegrin metalloproteáz, mutánsai, fragmentumai és hasonlók alkalmazása |
| US6436629B1 (en) | 2000-10-27 | 2002-08-20 | The Regents Of The University Of California | Modulating angiogenesis |
| US6294368B1 (en) | 2001-03-22 | 2001-09-25 | Applera Corporation | Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| AU2003207795B2 (en) * | 2002-01-31 | 2009-01-08 | Wyeth | Aggrecanase molecules |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0963432A4 (en) * | 1996-08-29 | 2002-11-20 | Univ California | KUZ, NEW FAMILY OF METALLOPROTEASES |
-
1997
- 1997-02-28 CA CA002247827A patent/CA2247827A1/en not_active Abandoned
- 1997-02-28 NZ NZ331844A patent/NZ331844A/en unknown
- 1997-02-28 AU AU20617/97A patent/AU2061797A/en not_active Abandoned
- 1997-02-28 JP JP9531177A patent/JPH11506023A/ja active Pending
- 1997-02-28 WO PCT/US1997/003217 patent/WO1997031931A1/en not_active Ceased
- 1997-02-28 KR KR1019980706866A patent/KR19990087444A/ko not_active Ceased
- 1997-02-28 EP EP97908799A patent/EP0888375A4/en not_active Withdrawn
-
1998
- 1998-08-28 NO NO983984A patent/NO983984L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983984D0 (no) | 1998-08-28 |
| EP0888375A4 (en) | 2001-04-11 |
| NZ331844A (en) | 2000-06-23 |
| JPH11506023A (ja) | 1999-06-02 |
| EP0888375A1 (en) | 1999-01-07 |
| KR19990087444A (ko) | 1999-12-27 |
| AU2061797A (en) | 1997-09-16 |
| CA2247827A1 (en) | 1997-09-04 |
| WO1997031931A1 (en) | 1997-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK104093D0 (da) | Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen | |
| WO1999042839A3 (en) | Treating cancer | |
| NO963371L (no) | Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det | |
| DE60140773D1 (de) | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) | |
| DK0953046T3 (da) | Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette | |
| DE59903915D1 (de) | Verfahren zur frühen diagnose von carcinomen | |
| DE69940969D1 (de) | Detektion von neoplasien durch speichelanalyse | |
| WO2002008767A3 (en) | Methods and kits for sequencing polypeptides | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| FR2816410B1 (fr) | Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire | |
| JPH02500022U (no) | ||
| AU3623197A (en) | Peptide reagent for the detection of human cytomegalovirus (cmv) | |
| FR2735238B1 (fr) | Utilisation d'un complexe phycobiliproteine-peptide de liaison en tant que traceur fluorescent | |
| NO924912L (no) | Fremgangsmaate ved paavisning av analyttvarianter, samt sett for utfoerelse av fremgangsmaaten | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| NO962084L (no) | DNA sekvens som koder for en BMP reseptor | |
| NO983984L (no) | Disintegrin-metalloprotease samt anvendelse derav | |
| AU7110796A (en) | Borate storage buffer and sample diluent | |
| ES8501630A1 (es) | Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo. | |
| IL144129A0 (en) | Methods and kits for sequencing polypeptides | |
| AU2174002A (en) | Method for analyzing proteins | |
| NO994056L (no) | Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav | |
| AP2368A (en) | Novel expression vectors and uses thereof. | |
| Maruyama et al. | Hemoglobins of the tadpole of the bullfrog, Rana catesbeiana. Amino acid sequence of the alpha chain of a major component. | |
| DK0973887T3 (da) | Porcin leptin-protein, nukleinsyresekvenser, som koder herfor, og anvendelser heraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |